You have 9 free searches left this month | for more free features.

Carcinoma, Papillary, Follicular

Showing 26 - 50 of 9,381

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

A Gene Hunting Study for Familial Papillary Thyroid Cancer

Recruiting
  • Thyroid
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Oct 13, 2022

    Papillary Thyroid Microcarcinoma Trial in Los Angeles (Active Surveillance)

    Recruiting
    • Papillary Thyroid Microcarcinoma
    • Active Surveillance
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jul 5, 2022

    Studies on Tumors of the Thyroid

    Recruiting
    • Hurthle Cell Thyroid Cancer
    • +4 more
    • 68-Gallium Dotatate
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Cross-sectional Case and Control Study on Quality of Life,

    Recruiting
    • Papillary Thyroid Carcinoma
    • Thyroid Cancer
    • Thyroid lobectomy via trans-axillary approach
    • Thyroid lobectomy via open approach
    • Beijing, Beijing, China
      Department of General Surgery, Peking Union Medical College Hosp
    Jul 5, 2023

    Thyroid Tumors Trial in Lexington (Lenalidomide)

    Completed
    • Thyroid Neoplasms
    • Lexington, Kentucky
      University of Kentucky Markey Cancer Center
    May 28, 2020

    Papillary Thyroid Carcinoma Trial in Guangzhou (retro-auricular single-site endoscopic thyroidectomy, traditional open surgery

    Recruiting
    • Papillary Thyroid Carcinoma
    • retro-auricular single-site endoscopic thyroidectomy
    • traditional open surgery thyroidectomy
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Apr 17, 2022

    Papillary Renal Cell Carcinoma Type 2 Trial in France (Axitinib Oral Tablet [Inlyta], Pembrolizumab Injection [Keytruda])

    Recruiting
    • Papillary Renal Cell Carcinoma Type 2
    • Axitinib Oral Tablet [Inlyta]
    • Pembrolizumab Injection [Keytruda]
    • Angers, France
    • +11 more
    Aug 26, 2022

    Papillary Thyroid Microcarcinoma, Thyroid, Thyroid Cancer Trial in New York (Percutaneous Laser Ablation (PLA))

    Recruiting
    • Papillary Thyroid Microcarcinoma
    • +2 more
    • Percutaneous Laser Ablation (PLA)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 14, 2022

    Thyroid Cancer Trial (Endoscopic surgery;)

    Not yet recruiting
    • Thyroid Cancer
    • Endoscopic surgery;
    • (no location specified)
    Jun 30, 2022

    Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland

    Completed
    • Refractory Differentiated Thyroid Gland Carcinoma
    • +4 more
    • Duarte, California
    • +32 more
    Jun 24, 2021

    Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

    Available
    • Clear Cell Kidney Cancer
    • +2 more
    • Axitinib 5 MG
    • (no location specified)
    Jul 3, 2023

    Thyroid Cancer Trial in Suita (Targeted alpha therapy)

    Recruiting
    • Thyroid Cancer
    • Targeted alpha therapy
    • Suita, Japan
      Osaka University Hospital
    Mar 2, 2022

    Predict Central Lymphnode Metastasis in Thyroid Papillary

    Completed
    • Thyroid Papillary Carcinoma
    • male
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital of Sun Yat-Sen University
    Dec 29, 2021

    Papillary Thyroid Carcinoma Trial in Guangzhou (Retro-Auricular Single-Site Endoscopic Thyroidectomy, Transoral Endoscopic

    Recruiting
    • Papillary Thyroid Carcinoma
    • Retro-Auricular Single-Site Endoscopic Thyroidectomy
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Mar 6, 2023

    Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

    Recruiting
    • Malignant Thyroid Gland Neoplasm
    • +6 more
    • Quality-of-Life Assessment
    • +3 more
    • Ann Arbor, Michigan
    • +1 more
    Jan 24, 2023

    Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

    Active, not recruiting
    • Renal Clear Cell Carcinoma
    • Renal Papillary Cell Carcinoma
    • London, United Kingdom
      Thomas Powles
    Aug 10, 2022

    Radioiodine Planar andSPECT/CT Imaging With Iodine-123 for

    Recruiting
    • Thyroid Gland Follicular Carcinoma
    • Computed Tomography
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Drainage, Thyroid Cancer Trial in Hangzhou (no drainage tube applied)

    Recruiting
    • Drainage
    • Thyroid Cancer
    • no drainage tube applied
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital School of Medicine Zhejiang Universit
    Jun 19, 2022

    RFA Treatment for Papillary Thyroid Microcarcinoma

    Recruiting
    • Papillary Thyroid Microcarcinoma
    • Radiofrequency Ablation
    • New York, New York
      Columbia University
    Dec 28, 2021

    Kidney Cancer Trial run by the NCI (INC280)

    Completed
    • Kidney Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 18, 2021

    Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

    Not yet recruiting
    • Non-Medullary Thyroid Carcinoma
    • Digoxin tablet
    • (no location specified)
    Aug 20, 2022

    Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Atezolizumab, Cabozantinib S-malate)

    Recruiting
    • Metastatic Papillary Renal Cell Carcinoma
    • Stage IV Renal Cell Cancer AJCC v8
    • Atezolizumab
    • +4 more
    • Sacramento, California
    • +38 more
    Jan 17, 2023

    Papillary Thyroid Microcarcinoma Trial in Hong Kong (Echopulse)

    Suspended
    • Papillary Thyroid Microcarcinoma
    • Echopulse
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    May 17, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +11 more
    • Cabozantinib S-malate
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

    Not yet recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +3 more
    • Chang chun, Jilin, China
      Jinlin Province Cancer Hosipital
    Dec 21, 2022